Schröder Sara L, Richter Matthias, Schröder Jochen, Frantz Stefan, Fink Astrid
Institute of Medical Sociology, Martin Luther University Halle-Wittenberg, Germany.
Institute of Medical Sociology, Martin Luther University Halle-Wittenberg, Germany.
Int J Cardiol. 2016 Sep 15;219:70-8. doi: 10.1016/j.ijcard.2016.05.066. Epub 2016 May 14.
Strong socioeconomic inequalities exist in cardiovascular mortality and morbidity. The current review aims to synthesize the current evidence on the association between socioeconomic status (SES) and access to treatment of coronary heart disease (CHD). We examined quantitative studies analyzing the relationship between SES and access to CHD treatment that were published between 1996 and 2015. Our data sources included Medline and Web of Science. Our search yielded a total of 2066 records, 57 of which met our inclusion criteria. Low SES was found to be associated with low access to coronary procedures and secondary prevention. Access to coronary procedures, especially coronary angiography, was mainly related to SES to the disadvantage of patients with low SES. However, access to drug treatment and cardiac rehabilitation was only associated with SES in about half of the studies. The association between SES and access to treatment for CHD was stronger when SES was measured based on individual-level compared to area level, and stronger for individuals living in countries without universal health coverage. Socioeconomic inequalities exist in access to CHD treatment, and universal health coverage shows only a minor effect on this relationship. Inequalities diminish along the treatment pathway for CHD from diagnostic procedures to secondary prevention. We therefore conclude that CHD might be underdiagnosed in patients with low SES. Our results indicate that there is an urgent need to improve access to CHD treatment, especially by increasing the supply of diagnostic angiographies, to reduce inequalities across different healthcare systems.
心血管疾病的死亡率和发病率存在显著的社会经济不平等。本综述旨在综合当前关于社会经济地位(SES)与冠心病(CHD)治疗可及性之间关联的证据。我们检索了1996年至2015年间发表的分析SES与CHD治疗可及性之间关系的定量研究。我们的数据来源包括Medline和科学网。我们的检索共得到2066条记录,其中57条符合我们的纳入标准。研究发现,低SES与冠心病治疗手段及二级预防的低可及性相关。冠心病治疗手段,尤其是冠状动脉造影的可及性,主要与SES相关,对低SES患者不利。然而,在约一半的研究中,药物治疗和心脏康复的可及性仅与SES相关。与基于地区层面衡量SES相比,基于个体层面衡量SES时,SES与CHD治疗可及性之间的关联更强,且对于生活在没有全民医保国家的个体而言关联更强。冠心病治疗的可及性存在社会经济不平等,全民医保对这种关系的影响较小。从诊断程序到二级预防,冠心病治疗过程中的不平等现象逐渐减少。因此,我们得出结论,低SES患者的冠心病可能未得到充分诊断。我们的结果表明,迫切需要改善冠心病治疗的可及性,尤其是增加诊断性血管造影的供给,以减少不同医疗体系间的不平等。